Projects funded by the NCN
In vivo effects, underlying signaling pathways and mechanism of action of ghrelin receptor agonist against pathological alpha-synuclein accumulation
2019/35/D/NZ7/03200
Keywords:
alpha-synuclein ghrelin receptor dopamine neurons Parkinson's Disease
Descriptors:
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
- NZ4_4: Pathophysiology
- NZ4_9: Systems neurobiology
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk
woj. małopolskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 5
Call: SONATA 15 - announced on 2019-09-16
Amount awarded: 1 055 333 PLN
Project start date (Y-m-d): 2020-07-20
Project end date (Y-m-d): 2023-07-19
Project duration:: 36 months (the same as in the proposal)
Project status: Project completed
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.